WHO ICTRP trial
Effect of esmolol- lignocaine infusion in improving cardiac functions and…
CTRI/2018/01/011555 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2018/01/011555 |
|---|---|
| Public title | Effect of esmolol- lignocaine infusion in improving cardiac functions and decreasing irregular heart beat post operatively when given during cardiac bypass surgeries. |
| Scientific title | Effect of on-pump esmolol- lignocaine infusion on post cardio-pulmonary bypass cardiac arrhythmias and function |
| Primary sponsor | CTVS ICU Advanced Cardiac centre PGIMER |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: I00-I99- Diseases of the circulatory system Health Condition 2: null- patients undergoing cardiac surgeries under cardiopulmonary bypass |
| Interventions | Intervention1: esmolol- lignocaine infusion: esmolol- lignocaine infusion in the test group @ 40 mcg/kg/min during the cross clamp time in CPB Control Intervention1: normal saline: as a placebo agent for preventing bias |
| Registration date | Jan 24, 2018 |
| Target size | 98 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: